Healthcare / Medical DistributionUpdated 2026-05-10 22:07 UTC

AIM/UPR stock hub

AIM/UPR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/UPRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

963M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/UPR

In the news

Latest news · AIM/UPR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.4

P25 12.9P50 16.9P75 23.5

Trailing P/E21.6

P25 15.9P50 22.9P75 35.8

ROE12.7

P25 -54.2P50 2.1P75 13.7

ROIC10.1

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/UPR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

228

Groups with data

Currency

EUR

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Ireland
Country code	UK
Employees	3,500
Employees Change	500%
Employees Change Percent	16.67
Enterprise value	GBX 1.2B
Exchange	London Stock Exchange AIM
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Distribution
Isin	IE00BJ5FQX74
Last refreshed	2026-05-10
Market cap	GBX 963M
Price	GBX 377
Price currency	GBX
Rev Per Employee	766,368.13x
Sector	Healthcare
Sic	5122
Symbol	aim/UPR
Website	https://www.uniphar.ie

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.63%
EV Earnings	27.99x
EV/EBIT	15.79x
EV/EBITDA	11.7x
EV/FCF	16.84x
EV/Sales	0.47x
FCF yield	7.69%
Forward P/E	16.44x
P/B ratio	2.72x
P/E ratio	21.61x
P/S ratio	0.36x
PE Ratio10 Y	18.29x
PE Ratio3 Y	13.8x
PE Ratio5 Y	14.34x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.97%
EBITDA Margin	3.49%
FCF margin	2.76%
Gross margin	14.89%
Gross Profit	GBX 399.3M
Gross Profit Growth	3.89%
Gross Profit Growth Q	7.76%
Gross Profit Growth3 Y	3.85%
Gross Profit Growth5 Y	5.6%
Net Income	GBX 44.6M
Net Income Growth	-20.43%
Net Income Growth Q	-31.16%
Net Income Growth Years	0%
Net Income Growth3 Y	4.19%
Net Income Growth5 Y	2.78%
Pretax Margin	2.05%
Profit Margin	1.66%
Profit Per Employee	GBX 12,734
Profitable Years	8
ROA	3.63
Roa5y	3.96
ROCE	10.19
ROE	12.67
Roe5y	16.54
ROIC	10.12
Roic5y	11.63

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	41.41%
Cagr3y	14.06%
Cagr5y	8.43%
Div CAGR3	4.71%
Div CAGR5	5.69%
EPS Growth	-17.02
EPS Growth Q	-27.59
EPS Growth Years	0
EPS Growth3 Y	5.73
EPS Growth5 Y	3.66
FCF Growth	89.85%
FCF Growth Q	2,017.68%
FCF Growth3 Y	-3.74%
FCF Growth5 Y	13.88%
OCF Growth	-12.74%
OCF Growth Q	52.57%
OCF Growth10 Y	5.09%
OCF Growth3 Y	-5.88%
OCF Growth5 Y	12.89%
Revenue Growth	10.98x
Revenue Growth Q	13.28x
Revenue Growth Quarters	7x
Revenue Growth Years	8x
Revenue Growth3 Y	4.67x
Revenue Growth5 Y	5.81x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 1.95
Assets	GBX 1.5B
Cash	GBX 160.3M
Current Assets	GBX 717M
Current Liabilities	GBX 722.2M
Debt	GBX 447.3M
Debt EBITDA	GBX 4.15
Debt Equity	GBX 1.27
Debt FCF	GBX 6.04
Equity	GBX 353.5M
Interest Coverage	4.49
Liabilities	GBX 1.2B
Long Term Assets	GBX 794.1M
Long Term Liabilities	GBX 435.5M
Net Cash	GBX -287M
Net Cash By Market Cap	GBX -29.8
Net Debt EBITDA	GBX 3.06
Net Debt Equity	GBX 0.81
Net Debt FCF	GBX 3.88
Tangible Book Value	GBX -164.1M
Tangible Book Value Per Share	GBX -0.63

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.99
Inventory Turnover	10.53
Net Working Capital	GBX -145.9M
Quick ratio	0.61
Working Capital	GBX -5.2M
Working Capital Turnover	GBX -64.72

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	4.1%
Dividend Growth	7.03%
Dividend Growth Years	3%
Dividend per share	GBX 0.02
Dividend Years	7
Dividend Yield	0%
Ex Div Date	2026-04-23
Last Dividend	GBX 0.01
Payout Frequency	Semi-Annual
Payout Ratio	9.95%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	41.38%
200-day SMA	336.3
3Y total return	48.39%
50-day SMA	347.1
50-day SMA vs 200-day SMA	50over200
5Y total return	49.86%
All Time High	416
All Time High Change	-9.38%
All Time High Date	2021-12-29
All Time Low	77.91
All Time Low Change	383.92%
All Time Low Date	2020-04-15
ATR	14.65
Ch YTD	26.09
High	380
High52	380
High52 Date	2026-05-08
High52ch	-0.79%
Low	363.3
Low52	262
Low52 Date	2025-05-08
Low52ch	43.89%
Ma50ch	8.62%
Price vs 200-day SMA	12.1%
RSI	76.15
RSI Monthly	63.76
RSI Weekly	63.76
Sharpe ratio	1.2x
Sortino ratio	2.19
Total Return	4.1%
Tr YTD	26.5
Tr1m	13.58%
Tr1w	6.8%
Tr3m	8.69%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX 79.8M
Operating Income Growth	2.11
Operating Income Growth Q	8.8
Operating Income Growth3 Y	5.02
Operating Income Growth5 Y	4.66
Operating margin	2.97

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	233,753,035%
Net Borrowing	78,105,441.1
Shares Insiders	5.07%
Shares Institutions	54.66%
Shares Qo Q	-1.73%
Shares Yo Y	-4.1%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX 70.8M
Average Volume	379,289.4x
Bv Per Share	1.36
CAPEX	GBX -20.5M
Ch1m	13.21
Ch1w	6.8
Ch1y	40.67
Ch3m	8.33
Ch3y	45.56
Ch5y	45.56
Ch6m	12.54
Change	1.89%
Change From Open	-0.79
Close	370
Days Gap	2.7
Depreciation Amortization	13,856,077.6
Dollar Volume	13,821,197
Earnings Date	2026-06-02
EBIT	GBX 79.8M
EBITDA	GBX 93.7M
EPS	GBX 0.17
F Score	6
FCF	GBX 74.1M
FCF EV Yield	5.94x
Financing CF	43,765,204
Fiscal Year End	December
Founded	1,967
Goodwill	432,141,285.1
Graham Number	233.064
Graham Upside	-38.18
Income Tax	GBX 10.3M
Investing CF	-67,285,249
Is Primary Listing	0
Last Earnings Date	2026-02-24
Last Report Date	2025-12-31
Lynch Fair Value	GBX 87.24
Lynch Upside	-76.86
Ma150	334.3
Ma150ch	12.77%
Ma20	353.9
Ma20ch	6.53%
Net CF	70,404,855
Next Earnings Date	2026-06-02
Open	380
P FCF Ratio	13
P OCF Ratio	10.18
Payment Date	2026-05-15
Position In Range	81.99
Ppne	260,514,673.1
Price Date	2026-05-08
Price EBITDA	GBX 10.27
Relative Volume	0.1x
Revenue	2,682,288,448x
SBC By Revenue	0.12x
Share Based Comp	3,285,356
Tax By Revenue	0.38x
Tax Rate	18.77%
Tr6m	12.9%
Volume	36,661
Z Score	2.5

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

AIM/UPR dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.0%

$0.02 annual per share

Payout ratio

+9.9%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+5.7%

3 consecutive years of growth

Total shareholder yield

+4.1%

Next ex-dividend date: 2026-04-23

Performance

AIM/UPR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/UPR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+54.7%

Share of float held by funds and institutions

Insider ownership

+5.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-4.1%

Negative means the company is buying back shares.

Technical

AIM/UPR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

76.2

Above 70: short-term overbought

Price vs 200-day MA

+12.1%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.20

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/UPR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/UPR stock rating?

aim/UPR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/UPR analysis?

The full report lives at /stocks/aim/UPR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/UPR?

The latest report frames aim/UPR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/UPR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.